The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling

Ailin Luo(Tongji Hospital), Chun Yang(Jiangsu Province Hospital)

Journal of Translational Medicine

February 2, 2023

10.1186/s12967-023-03917-x

Cited by 31

Related Papers

Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies

|Neuroscience & Biobehavioral Reviews|2022|151

Caffeic Acid Phenethyl Ester Suppresses Oxidative Stress and Regulates M1/M2 Microglia Polarization via Sirt6/Nrf2 Pathway to Mitigate Cognitive Impairment in Aged Mice following Anesthesia and Surgery

|Antioxidants|2023|65

Cefazolin Improves Anesthesia and Surgery-Induced Cognitive Impairments by Modulating Blood-Brain Barrier Function, Gut Bacteria and Short Chain Fatty Acids

|Frontiers in Aging Neuroscience|2021|52